Obstructive lung diseases burden and COVID-19 in developing countries: a perspective.

ABSTRACT:

Purpose of review

Asthma and chronic obstructive pulmonary disease (COPD) are widely prevalent disorders, and important contributors to morbidity and mortality, in both developing and developed countries. It is conjectured that these obstructive lung diseases may have had more deleterious effects in developing nations during the 2019 coronavirus disease (COVID-19) pandemic. We provide an evidence-based perspective on the relationship between asthma/COPD prevalence and COVID-19 burden, and the impact of comorbid asthma/COPD on selected COVID-19 outcomes and healthcare utilization, with special reference to developing countries.

Recent findings

Developing countries with higher COPD (but not asthma) prevalence appear to have higher COVID-19 related mortality. Patients with asth

SUBMITTER: Aggarwal AN 

PROVIDER: S-EPMC8815642 | biostudies-literature | 2022 Mar

REPOSITORIES: biostudies-literature